Fernand Labrie

CONGRESSES & CONFERENCES

Page 5 of 27, showing 20 records out of 532 total, starting on record 81, ending on 100

Event Where When
Title
11th International Congress on Hormonal Steroids & Hormones and Cancer, “DHEA and Bone”, Fukuoka, Japan (October 2002) 2002
U.S. Endocrine Society Meeting (2001): Current Developments in Menopaue Management, “Intracrinology (Locally-Produced Androgens and Estrogens) in Menopause ”, Denver (June 2001) 2001
VII International Congress of Andrology, Plenary Debate on « Screening of Prostate Cancer », Montreal (June 2001) 2001
Reasons for Hope 2001 - Canadian Breast Cancer Research Initiative, Plenary session on “New Developments in Breast Cancer Research”, “Les modulateurs sélectifs des récepteurs des estrogènes et la sant 2001
6th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “A Strong Candidate Prostate Cancer Predisposition Gene at Chromosome 17p”, Geneva (February 2001) 2001
6th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “Key Role of GnRH Agonists in the First Pivotal Studies Shown to Improve Survival in Localized Prostate Cancer”, Geneva 2001
11th International Prostate Cancer Update, “The Quebec Screening Study”, Vail (February 2001) 2001
11th International Prostate Cancer Update, “Hormone Therapy Mardekly Decreases Deaths in Localized Disease”, Vail (February 2001) 2001
11th International Prostate Cancer Update, “Susceptibility Genes for Prostate Cancer“, Vail (February 2001) 2001
2001 Congress on Uro-Oncology: A Canada-Mexico Alliance, Ixtapa (January 2001) 2001
3rd Croatian Congress on Menopause and Gynecological Endocrinology, “Role of Androgens in Women and Potential Use of DHEA as Hormonal Replacement Therapy”, Dubrovnik (August 2001) 2001
3rd Croatian Congress on Menopause and Gynecological Endocrinology, “EM-652 (SCH-57068), an Ideal 4th-Generation SERM for Protection of Women’s Health ”, Dubrovnik (August 2001) 2001
9th World Congress of Gynecological Endocrinology, “SERMs – From Pure Estrogen Antagonists to Complete Agonists”, Hong Kong (December 2001) 2001
International Workshop – Androgens 2001, “Androgens and Prostate Cancer”, Montpellier (December 2001) 2001
3rd Macedonian Symposium on Urology, “Status of Androgen Blockade in Prostate Cancer in 2001: Impact on Survival”, Thessaloniki (November 2001) 2001
Third International FGOG Meeting, Endocrine Treatment and Prevention of Breast and Gynaecological Cancers, “The Advantageous Profile of EM-652- (SCH-57068) for Women’s Health Objectives”, Bruxelles (N 2001
North American Menopause Society, Symposium on The Role of Androgen Therapy in Post-Menopausal Women, “Multiple Sources and Physiology of Androgens in Women”, New Orleans (October 2001) 2001
Annual Female Sexual Function Forum – Plenary and State-of-the-Art Lecture, “Role of Steroid Hormones as they Pertain to Female Sexual Functions”, Boston (October 2001) 2001
Annual Female Sexual Function Forum: Androgen Deficiency Syndrome in Women: Implications and Mechanisms and Treatments, “Role of Androgens and their Precursor DHEA in Women”, Boston (October 2001) 2001
First World Congress – Update in Androgen Disorders, “Major Impact on Survival of Androgen Blockade in Localized Prostate Cancer”, Gubbio, Italy (September 2001) 2001
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards